Preprint · OA
via OpenAlex
Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease
Bartolomé R. Celli, Nicholas Locantore, Julie Yates, Ruth Tal‐Singer, Bruce E. Miller, Per Bakke, Peter M.A. Calverley, Harvey O. Coxson, Courtney Crim, Lisa Edwards, David A. Lomas, Annelyse Duvoix, William MacNee, Stephen I. Rennard, Edwin K. Silverman
American Journal of Respiratory and Critical Care Medicine · 2012 · ▲ 430 citations
Abstract
RATIONALE: Accurate prediction of mortality helps select patients for interventions aimed at improving outcome. OBJECTIVES: Because chronic obstructive pulmonary disease is characterized by low-grade systemic inflammation, we hypothesized that addition of inflammatory biomarkers to established predictive factors will improve accuracy. METHODS: A total of 1,843 patients enrolled in the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study were followed for 3 years. Kaplan-Meier curves, log-rank analysis, and Cox proportional hazards analyses determined the predictive value for mortality of clinical variables, while C statistics assessed the added discriminative power offered by addition of biomarkers. MEASUREMENTS AND MAIN RESULTS: At recruitment we measured anthropometrics, spirometry, 6-minute walk distance, dyspnea, BODE index, history of hospitalization, comorbidities, and computed tomography scan emphysema. White blood cell and neutrophil counts, serum or plasma levels of fibrinogen, chemokine ligand 18, surfactant protein D, C-reactive protein, Clara cell secretory protein-16, IL-6 and -8, and tumor necrosis factor-α were determined at recruitment and subsequent visits. A total of 168 of the 1,843 patients (9.1%) died. Nonsurvivors were older and had more severe airflow limitation, increased dyspnea, higher BODE score, more emphysema, and higher rates of comorbidities and history of hospitalizations. The best predictive model for mortality using clinical variables included age, BODE, and hospitalization history (C statistic of 0.686; P < 0.001). One single biomarker (IL-6) significantly improved the C statistic to 0.708, but this was further improved to 0.726 (P = 0.003) by the addition of all biomarkers. CONCLUSIONS: The addition of a panel of selected biomarkers improves the ability of established clinical variables to predict mortality in chronic obstructive pulmonary disease. Clinical trial registered with www.clinicaltrials.gov (NCT00292552).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1164/rccm.201110-1792oc
- Canonical
- link ↗
- Fetched
- 2026-07-28 MST
Cite this
APA
Celli, B.R., Locantore, N., Yates, J., Tal‐Singer, R., Miller, B.E., Bakke, P., Calverley, P.M., Coxson, H.O., Crim, C., Edwards, L., Lomas, D.A., Duvoix, A., MacNee, W., Rennard, S.I., Silverman, E.K., Vestbo, J., Wouters, E.F., & Agustí, �. (2012). Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease. <em>American Journal of Respiratory and Critical Care Medicine</em>. https://doi.org/10.1164/rccm.201110-1792oc
Vancouver
Celli BR, Locantore N, Yates J, Tal‐Singer R, Miller BE, Bakke P, et al. Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 2012. doi:10.1164/rccm.201110-1792oc.
BibTeX
@unpublished{bartolom2012Inflam,
title = {Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease},
author = {Bartolomé R. Celli and Nicholas Locantore and Julie Yates and Ruth Tal‐Singer and Bruce E. Miller and Per Bakke and Peter M.A. Calverley and Harvey O. Coxson and Courtney Crim and Lisa Edwards and David A. Lomas and Annelyse Duvoix and William MacNee and Stephen I. Rennard and Edwin K. Silverman and Jørgen Vestbo and Emiel F.�M. Wouters and Àlvar Agustí},
journal = {American Journal of Respiratory and Critical Care Medicine},
year = {2012},
doi = {10.1164/rccm.201110-1792oc},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Thoracic Disease 2021
Open access · CC-BY
Inflammatory parameters and pulmonary biomarkers in smokers with and without chronic obstructive pulmonary disease (COPD)
ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS 2025
Open access · CC-BY
INTERLEUKIN-6 AND ACUTE PHASE PROTEINS AS BIOMARKERS OF SEPTIC OSTEOARTHRITIS
Thorax 2005
Open access · OA
Raised CRP levels mark metabolic and functional impairment in advanced COPD
Circulation 2023
Citation only
Abstract 17447: Effects of Inflammatory Biomarkers on Epigenetic Age Acceleration in Adult Congenital Heart Disease
Journal of the American Heart Association 2017
Open access · CC-BY
Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
Diagnostics 2020
Open access · CC-BY